![Corinne Hoff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Corinne Hoff
Geen lopende functies
Loopbaan van Corinne Hoff
Eerdere bekende functies van Corinne Hoff
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Exonhit
![]() Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Public Communications Contact | 19-07-2010 | 20-12-2012 |
NOVARTIS AG | Public Communications Contact | - | - |
Statistieken
Internationaal
Zwitserland | 2 |
Frankrijk | 2 |
Operationeel
Public Communications Contact | 2 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NOVARTIS AG | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Exonhit
![]() Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
- Beurs
- Insiders
- Corinne Hoff
- Ervaring